Latest EU patient information plan includes fresh drug safety measures
This article was originally published in SRA
The latest draft of the European Commission's proposed legislation on patient information will allow pharmaceutical companies to provide information on their prescription drugs to the public, but only in a very circumscribed manner. It will also place an obligation on them to make certain information available, such as the product's labelling and pack leaflet.
You may also be interested in...
The Russian backers of the vaccine’s development say that if it receives a marketing authorization in the EU, distribution could begin in June this year.
Coronavirus Notebook: EU Moots Emergency Use Authorization Scheme For Vaccines, Janssen Product Up For 11 March Approval
Celltrion’s regdanvimab is undergoing an emergency use procedure in Europe, the European Medicines Agency and the health authorities in Canada have jointly published clinical data on the Moderna vaccine, and Canada has approved two versions of the AstraZeneca/Oxford University jab.
While the EU attempts to accelerate the pace of its unified approach to vaccine roll-out, some eastern European countries are taking their own decisions.